drugset / Trial / NCT00054002

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

NCT00054002

Phase 2 Completed 12 enrolled Roswell Park Cancer Institute
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill cancer cells. Combining photodynamic therapy with surgery may be an effective treatment for malignant mesothelioma. PURPOSE: Phase II trial to study the effectiveness of combining photodynamic therapy with surgery in treating patients who have malignant mesothelioma.

Timeline

Start
1999-03
Primary completion
2006-06
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule Intravenous